ThredUp Inc (TDUP) Stock Price Today
Aura AI Summary
Key Stats
- $171.58MMarket Cap
- 2,490,453Volume
- Consumer CyclicalSector
- $8.7252W High
- $1.2952W Low
- 30 DaysTypical Hold Time
- $165.78MEnterprise Value
- -Div Yield
- -Trading Activity
Track ThredUp Inc (TDUP) stock price today on Pluang, updated in real time with live charts and market data. Over the past 52 weeks, ThredUp Inc has traded between a low of $1.29 and a high of $8.72, highlighting its annual price range. Buy and sell ThredUp Inc shares on Pluang with fractional shares and real-time market data — safe and OJK-regulated.
About ThredUp Inc
ThredUp Inc is an online resale platform for women and kids apparel, shoes, and accessories. It generates revenue from items that are sold to buyers through the website, mobile app, and RaaS partners.
Most Recent News
NVIDIA Board launches probe into CEO Jensen Huang over foreign intelligence concerns.
NVIDIA's Board of Directors has started an independent investigation after reports that CEO Jensen Huang was targeted by a foreign intelligence operation. The inquiry, led by independent directors and external counsel, aims to ensure no national secu...

CRISPR Therapeutics reports positive Phase 1 results for zugo-cel in treating refractory autoimmune diseases.
CRISPR Therapeutics announced encouraging Phase 1 trial results for zugo-cel, their gene-edited CAR-T cell therapy targeting refractory autoimmune diseases like systemic sclerosis, lupus, and idiopathic inflammatory myopathy. Among 21 patients treate...

Velinotamig shows strong safety and efficacy in treating refractory systemic lupus erythematosus, with notable kidney improvements.
Cullinan Therapeutics announced promising Phase 1b/2a trial results for velinotamig, a BCMAxCD3 T cell engager, in patients with refractory moderate-to-severe systemic lupus erythematosus (SLE). Among nine evaluable patients, eight showed significant...

People also bought
Frequently Asked Questions
All investments involve risks and the possibility of a loss in investment value. Past performance is not indicative of future results. Historical performance, expected returns, and probability projections are provided for informational and illustrative purposes only.